This letter confirms the agreement between Foundation Medicine, Inc. and Gates Ventures, LLC, granting Gates Ventures certain management rights in connection with their purchase of Series B Preferred Stock. The rights include quarterly telephone conferences and annual meetings with the CEO, subject to confidentiality provisions. The agreement outlines conditions for termination of these rights and non-transferability, except to affiliates. It also includes a clause regarding the involvement of the Bill & Melinda Gates Foundation.
documents/EFTA01143358.pdf
{}